software as a medical device
The FDA clearance comes just three months after the company received EU MDR Class IIb certification for its configurable disease management platform.
With the abrupt transition to telehealth, the paradigm of care has shifted from legacy thinking to digital innovation
This morning, the FDA published its 17-page first draft of a working model for its pre-certification program for software as a medical device (SaMD).
A recently released analysis report from the Deloitte Center for Government Insights that examines the US’s current and proposed software as a medical device (SaMD) regulatory landscape, and includes suggestions on how the FDA’s pre-certification pilot program and other initiatives could better serve this fast-moving industry.